Pan-3C Protease Inhibitor Rupintrivir Binds SARS-CoV-2 Main Protease in a Unique Binding Mode.


Journal

Biochemistry
ISSN: 1520-4995
Titre abrégé: Biochemistry
Pays: United States
ID NLM: 0370623

Informations de publication

Date de publication:
05 10 2021
Historique:
pubmed: 11 9 2021
medline: 13 10 2021
entrez: 10 9 2021
Statut: ppublish

Résumé

Rupintrivir targets the 3C cysteine proteases of the picornaviridae family, which includes rhinoviruses and enteroviruses that cause a range of human diseases. Despite being a pan-3C protease inhibitor, rupintrivir activity is extremely weak against the homologous 3C-like protease of SARS-CoV-2. In this study, the crystal structures of rupintrivir were determined bound to enterovirus 68 (EV68) 3C protease and the 3C-like main protease (M

Identifiants

pubmed: 34506130
doi: 10.1021/acs.biochem.1c00414
doi:

Substances chimiques

Antiviral Agents 0
Cysteine Proteinase Inhibitors 0
Isoxazoles 0
Pyrrolidinones 0
Phenylalanine 47E5O17Y3R
3C-like proteinase, SARS-CoV-2 EC 3.4.22.-
Coronavirus 3C Proteases EC 3.4.22.28
Valine HG18B9YRS7
rupintrivir RGE5K1Q5QW

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

2925-2931

Subventions

Organisme : NIGMS NIH HHS
ID : P30 GM133893
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM135919
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI149716
Pays : United States
Organisme : NIGMS NIH HHS
ID : R35 GM118112
Pays : United States

Auteurs

Gordon J Lockbaum (GJ)

Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, Massachusetts 01605, United States.

Mina Henes (M)

Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, Massachusetts 01605, United States.

Jeong Min Lee (JM)

Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, Massachusetts 01605, United States.

Jennifer Timm (J)

Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, Massachusetts 01605, United States.

Ellen A Nalivaika (EA)

Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, Massachusetts 01605, United States.

Paul R Thompson (PR)

Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, Massachusetts 01605, United States.

Nese Kurt Yilmaz (N)

Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, Massachusetts 01605, United States.

Celia A Schiffer (CA)

Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, Massachusetts 01605, United States.

Articles similaires

Humans Multiple Myeloma Male Aged Glomerulosclerosis, Focal Segmental
Animals Swine Antiviral Agents Swine Diseases Coronavirus Infections

Total elbow arthroplasty in England.

Zaid Hamoodi, Adrian Sayers, Michael R Whitehouse et al.
1.00
Humans England Female Male Arthroplasty, Replacement, Elbow
Humans COVID-19 Immunoglobulin G Antibodies, Viral SARS-CoV-2

Classifications MeSH